A recent study on the prevalence and marketing practices of businesses offering stem cell treatments internationally noted the presence of the following elements in their marketing practices:

• Mentions of affiliations with a professional society or network
• Claims of partnerships with academic institutions
• Statements of receipt of FDA approval, or explicit mention of exemption from FDA oversight
• Mention of official endorsement from a local or other authority, or professional accreditation
• Listing of patents granted
• Statement that clinical trials of investigational stem cell-based interventions are being conducted